AngusDC, Linde-ZwirbleWT, LidickerJ, et al.Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001; 29:1303–1310.
2.
MayrFB, YendeS, AngusDC. Epidemiology of severe sepsis. Virulence. 2014; 5:4–11.
3.
DombrovskiyVY, MartinAA, SunderramJ, PazHL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med, 2007; 35:1244–1250.
4.
MartinGS, ManninoDM, EatonS, MossM. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 2003; 348:1546–1554.
DeitchEA. Animal models of sepsis and shock: A review and lessons learned. Shock, 1998; 9:1–11.
7.
OsuchowskiMF, RemickDG, LedererJA, et al.Abandon the mouse research ship?. Not just yet! Shock, 2014; 41:463–475.
8.
van der PollT. Preclinical Sepsis Models. Surg Infect, 2012; 13:121009060607009.
9.
IskanderKN, OsuchowskiMF, Stearns-KurosawaDJ, et al.Sepsis: Multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev, 2013; 93:1247–1288.
10.
MarshallJC, DeitchE, MoldawerLL, et al.Preclinical models of shock and sepsis: what can they tell us?. Shock, 2005; 24(Suppl 1):1–6.
11.
RiversE, NguyenB, HavstadS, et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 2001; 345:1368–1377.
12.
OteroRM, NguyenHB, HuangDT, et al.Early goal-directed therapy in severe sepsis and septic shock revisited: Concepts, controversies, and contemporary findings. Chest, 2006; 130:1579–1595.
13.
InvestigatorsTP. A randomized trial of protocol-based care for early septic shock. Process trial. N Engl J Med, 2014; 370:1–11.
14.
MounceyPR, OsbornTM, PowerGS, et al.Trial of early, goal-directed resuscitation for septic shock. N Engl J Med, 2015; 372:1301–1311.
15.
PeakeSEA. Goal-Directed Resuscitation for Patients with Early Septic Shock. N Engl J Med, 2015; 371:1496–1506.
16.
FinkMP. Animal models of sepsis. Virulence, 2014; 5:143–153.
17.
SeokJ, WarrenHS, CuencaAG, et al.Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA, 2013; 110:3507–3512.
18.
EfronPA, MohrAM, MooreFA, MoldawerLL. The future of murine sepsis and trauma research models. J Leukoc Biol, 2015; 98:1–8.
19.
TakaoK, MiyakawaT. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci, 2015; 112:1167–1172.
20.
Poli-de-FigueiredoLF, GarridoAG, NakagawaN, SannomiyaP. Experimental models of sepsis and their clinical relevance. Shock, 2008; 30(Suppl 1):53–59.
21.
DeitchEA. Rodent models of intra-abdominal infection. Shock, 2005; 24Suppl 1:19–23.
22.
RemickDG, WardPA. Evaluation of endotoxin models for the study of sepsis. Shock, 2005; 24(Suppl 1):7–11.
23.
ChenP, StanojcicM, JeschkeMG. Differences between murine and human sepsis. Surg Clin North Am, 2014; 94:1135–1149.
24.
RittirschD, HoeselLM, WardPA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol, 2007; 81:137–143.
25.
RemickDG, NewcombDE, BolgosGL, CallDR. Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide vs. cecal ligation and puncture. Shock, 2000; 13:110–116.
26.
RemickD, ManoharP, BolgosG, et al.Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock, 1995; 4:89–95.
27.
AhrenholzD, SimmonsR. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery, 1980; 88:41–47.
28.
MathiakG, SzewczykD, AbdullahF, et al.An improved clinically relevant sepsis model in the conscious rat. Crit Care Med, 2000; 28:1947–1952.
29.
KumarA, HaeryC, PaladuguB, et al.The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: Association with serum lactate and inflammatory cytokine levels. J Infect Dis, 2006; 193:251–258.
30.
MourelatosMG, EnzerN, FergusonJL, et al.The effects of diaspirin crosslinked hemoglobin in sepsis. Shock, 1996; 5:141–148.
31.
StarrME, SteeleAM, SaitoM, et al.A new cecal slurry preparation protocol with improved long-term reproducibility for animal models of sepsis. PLoS One, 2014; 9:e115705.
32.
GentileLF, NacionalesDC, LopezMC, et al.Host responses to sepsis vary in different low-lethality murine models. PLoS One, 2014; 9:1–10.
33.
WynnJL, ScumpiaPO, DelanoMJ, O'MalleyKA, et al.Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock, 2007; 28:1.
34.
GentileLF, NacionalesDC, LopezMC, et al.Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol, 2014; 192:3156–3165.
35.
WichtermanKA, BaueAE, ChaudryIH. Sepsis and septic shock–a review of laboratory models and a proposal. J Surg Res, 1980; 29:189–201.
36.
BakerCC, ChaudryIH, GainesHO, BaueAE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery, 1983; 94:331–335.
37.
DejagerL, PinheiroI, DejonckheereE, LibertC. Cecal ligation and puncture: The gold standard model for polymicrobial sepsis?. Trends Microbiol, 2011; 19:198–208.
38.
EbongS, CallD, NemzekJ, et al.Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun, 1999; 67:6603–6610.
39.
HubbardWJ, ChoudhryM, SchwachaMG, et al.Cecal ligation and puncture. Shock, 2005; 24:52–57.
40.
YangS, ChungCS, AyalaA, et al.Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock, 2002; 17:55–60.
41.
TaoW, DeyoDJ, TraberDL, et al.Hemodynamic and cardiac contractile function during sepsis caused by cecal ligation and puncture in mice. Shock, 2004; 21:31–37.
42.
AyalaA, SongGY, ChungCS, et al.Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin. Crit Care Med, 2000; 28:2949–2955.
43.
XiaoH, SiddiquiJ, RemickDG. Mechanisms of mortality in early and late sepsis. Infect Immun, 2006; 74:5227–5235.
44.
KuetheJW, MiduraEF, RiceTC, CaldwellCC. Peritoneal wash contents used to predict mortality in a murine sepsis model. J Surg Res, 2015; 199:1–9.
45.
HollenbergSM, DumasiusA, EasingtonC, et al.Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med, 2001; 164:891–895.
46.
LewisAJ, YuanD, ZhangX, et al.Use of biotelemetry to define physiology-based deterioration thresholds in a murine cecal ligation and puncture model of sepsis. Crit Care Med, 2016 [Epub ahead of print].
47.
TurnbullIR, JavadiP, BuchmanTG, et al.Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels. Shock, 2004; 21:121–125.
48.
NewcombD, BolgosG, GreenL, RemickDG. Antibiotic treatment influences outcome in murine sepsis: Mediators of increased morbidity. Shock, 1998; 10:110–117.
49.
ViannaRCS, GomesRN, BozzaFA, et al.Antibiotic treatment in a murine model of sepsis: Impact on cytokines and endotoxin release. Shock, 2004; 21:115–120.
50.
VyasD, JavadiP, DipascoPJ, et al.Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. Am J Physiol Regul Integr Comp Physiol, 2005; 289:R1048–R1053.
51.
LeeHT, EmalaCW, JooJD, KimM. Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis. Shock, 2007; 27:373–379.
52.
HerrmannI, CastellonM, SchwartzD, et al.Volatile anesthetics improve survival after cecal ligation and puncture. Anesthesiology, 2013; 119:901–906.
53.
YuM, ShaoD, YangR, et al.Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis. J Pharm Pharm Sci, 2007; 10:434–442.
54.
HowellGM, GomezH, CollageRD, et al.Augmenting autophagy to treat acute kidney injury during endotoxemia in mice. PLoS One, 2013; 8:1–7.
MiyajiT, HuX, YuenPST, et al.Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int, 2003; 64:1620–1631.
57.
HotchkissRS, SwansonPE, FreemanBD, et al.Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med, 1999; 27:1230–1251.
58.
IskanderKN, CraciunFL, StepienDM, et al.Cecal ligation and puncture-induced murine sepsis does not cause lung injury. Crit Care Med, 2013; 41:159–170.
59.
DoerschugKC, PowersLS, MonickMM, et al.Antibiotics delay but do not prevent bacteremia and lung injury in murine sepsis. Crit Care Med, 2004; 32:489–494.
60.
BhargavaR, AltmannCJ, Andres-HernandoA, et al.Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-α antibodies. PLoS One, 2013; 8:1–11.
61.
ZantlN, UebeA, NeumannB, et al.Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun, 1998; 66:2300–2309.
62.
MaierS, TraegerT, EntleutnerM, et al.Cecal ligation and puncture versus colon ascendens stent peritonitis: Two distinct animal models for polymicrobial sepsis. Shock, 2004; 21:505–511.
63.
BarthlenW, ZantlN, PfefferK, et al.Impact of experimental peritonitis on bone marrow cell function. Surgery, 1999; 126:41–47.
64.
NeumannB, ZantlN, VeihelmannA, et al.Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int Immunol, 1999; 11:217–227.
65.
MaierS, EmmanuilidisK, EntleutnerM, et al.Massive chemokine transcription in acute renal failure due to polymicrobial sepsis. Shock, 2000; 14:187–192.
66.
LustigMK, BacVH, PavlovicD, et al.Colon ascendens stent peritonitis—a model of sepsis adopted to the rat: Physiological, microcirculatory and laboratory changes. Shock, 2007; 28:59–64.
67.
MiaoP, KongY, MaY, et al.Hypothermia predicts the prognosis in colon ascendens stent peritonitis mice. J Surg Res, 2013; 181:129–135.
68.
XiaoH, RemickDG. Correction of perioperative hypothermia decreases experimental sepsis mortality by modulating the inflammatory response. Crit Care Med, 2005; 33:161–167.
69.
CoopersmithCM, StrombergPE, DunneWM, et al.Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. Jama, 2002; 287:1716–1721.
70.
KnappS, SchultzMJ, van der PollT. Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock, 2005; 24(Suppl 1):12–18.
71.
CoopersmithCM, AmiotDM, StrombergPE, et al.Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia. Shock, 2003; 19:408–414.
72.
MuenzerJT, DavisCG, DunneBS, et al.Pneumonia after cecal ligation and puncture. Shock, 2006; 26:565–570.
73.
SteinhauserML, HogaboamCM, KunkelSL, et al.IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol, 1999; 162:392–399.
74.
HagbergL, EngbergI, FreterR, et al.Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun, 1983; 40:273–283.
75.
HagbergL, HullR, HullS, et al.Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun, 1983; 40:265–272.
76.
RoeschPL, RedfordP, BatcheletS, et al.Uropathogenic Escherichia coli use D-serine deaminase to modulate infection of the murine urinary tract. Mol Microbiol, 2003; 49:55–67.
77.
SvenssonM, YadavM, HolmqvistB, et al.Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice. Kidney Int, 2011; 80:1064–1072.
78.
TorresAG, RedfordP, WelchRA, PayneSM. TonB-dependent systems of uropathogenic Escherichia coli: Aerobactin and heme transport and TonB are required for virulence in the mouse. Infect Immun, 2001; 69:6179–6185.
79.
HydeSR, StithRD, McCallumRE. Mortality and bacteriology of sepsis following cecal ligation and puncture in aged mice. Infect Immun, 1990; 58:619–624.
80.
TurnbullIR, ClarkAT, StrombergPE, et al.Effects of aging on the immunopathologic response to sepsis. Crit Care Med, 2009; 37:1018–1023.
81.
SaitoH, SherwoodER, VarmaTK, EversBM. Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech Ageing Dev, 2003; 124:1047–1058.
82.
TurnbullIR, WizorekJJ, OsborneD, et al.Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock, 2003; 19:310–313.
83.
WichmannMW, ZellwegerR, DeMasoCM, et al.Mechanism of immunosuppression in males following trauma-hemorrhage. Critical role of testosterone. Arch Surg, 1996; 131:1186–1191.
84.
WichmannMW, ZellwegerR, DeMasoCM, et al.Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine, 1996; 8:853–863.
85.
ZellwegerR, WichmannMW, AyalaA, et al.Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med, 1997; 25:106–110.
86.
EbongSJ, CallDR, BolgosG, et al.Immunopathologic responses to non-lethal sepsis. Shock, 1999; 12:118–126.
87.
OsuchowskiMF, ConnettJ, WelchK, et al.Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med, 2009; 37:1567–1573.
88.
RemickDG, BolgosGR, SiddiquiJ, et al.Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock, 2002; 17:463–467.
89.
NemzekJA, XiaoHY, MinardAE, et al.Humane endpoints in shock research. Shock, 2004; 21:17–25.
90.
HuetO, RamseyD, MiljavecS, et al.Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock. Shock, 2013; 39:488–494.
91.
ShrumB, AnanthaRV, XuSX, et al.A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes, 2014; 7:233.
92.
OsuchowskiMF, WelchK, SiddiquiJ, RemickDG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol, 2006; 177:1967–1974.
